Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial)

被引：0
|
作者：
Nieves Martinez Chanza
Louisa Soukane
Philippe Barthelemy
Aurélien Carnot
Thierry Gil
Vinciane Casert
Vincent Vanhaudenarde
Brieuc Sautois
Lionel Staudacher
Jan Van den Brande
Stephane Culine
Emmanuel Seront
Marco Gizzi
Simone Albisinni
Thibault Tricard
Jean Christophe Fantoni
Marianne Paesmans
Rafael Caparica
Thierry Roumeguere
Ahmad Awada
机构：
[1] Jules Bordet Institute,Hopital Erasme
[2] Université Libre de Bruxelles,Clinique Sainte
[3] Université Libre de Bruxelles,Elisabeth
[4] Institut de Cancérologie Strasbourg Europe ICANS,undefined
[5] Centre Oscar Lambret,undefined
[6] Centre Hospitalier Universitaire de Ambrois Paré,undefined
[7] UCL,undefined
[8] University Hospital of Liege (CHU Sart Tilman),undefined
[9] Hopital Paris Saint Joseph,undefined
[10] University Hospital Antwerp,undefined
[11] UZA,undefined
[12] Hopital Saint-Louis,undefined
[13] Hopital de Jolimont,undefined
[14] Grand Hopital de Charleroi,undefined
来源：
BMC Cancer | / 21卷
关键词：
Avelumab; Bladder cancer; Checkpoint inhibitor; Immunotherapy; Neoadjuvant; PD-1 blockade; Urothelial carcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Phase II trial of BC-819 intravesical gene therapy in combination with BCG in patients with non-muscle invasive bladder cancer (NMIBC).
    Halachmi, Sarel
    Leibovitch, Ilan
    Zisman, Amnon
    Stein, Avi
    Benjamin, Shalva
    Sidi, Ami
    Knickerbocker, Ron
    Limor, Michal
    Moore, Yan
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [42] EFFICACY AND SAFETY OF TWO NEOADJUVANT STRATEGIES WITH BEVACIZUMAB IN LOCALLY ADVANCED RESECTABLE RECTAL CANCER: INTERIM RESULTS OF A RANDOMIZED, NON-COMPARATIVE PHASE II STUDY
    Bosset, J.
    Mantion, G.
    Andre, T.
    Boudghene, F.
    Piard, F.
    Mornex, F.
    Maingon, P.
    Adenis, A.
    Piutti, M.
    Borg, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 206 - 206
  • [43] COMPARATIVE EFFECTIVENESS OF CONSERVATIVE THERAPY VERSUS CYSTECTOMY FOR NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS
    Dinh, T.
    VALUE IN HEALTH, 2013, 16 (07) : A408 - A408
  • [44] HUMANISTIC BURDEN OF RADICAL CYSTECTOMY (RC) AMONG PATIENTS WITH NON-MUSCLE INVASIVE (NMIBC) OR NON-METASTATIC MUSCLE INVASIVE BLADDER CANCER (MIBC): A SYSTEMATIC LITERATURE REVIEW (SLR)
    Eccleston, A.
    Koshy, A.
    Musat, M.
    Tzonev, C.
    Brinkmann, J.
    Chang, J.
    VALUE IN HEALTH, 2024, 27 (12)
  • [45] THE BENEFIT OF A NEOADJUVANT INSTILLATION OF CHEMOTHERAPY IN NON-MUSCLE INVASIVE BLADDER CANCER: INTERIM ANALYSIS OF THE PRECAVE RANDOMIZED CLINICAL TRIAL
    Carrion, Diego M.
    Gomez Rivas, Juan
    Aguilera Bazan, Alfredo
    Ballesteros Ruiz, Cristina
    Alvarez-Maestro, Vario
    Rios Gonzalez, Emilio
    Martinez-Pineiro, Luis
    ARCHIVOS ESPANOLES DE UROLOGIA, 2021, 74 (09): : 883 - 893
  • [46] A phase II study of neoadjuvant chemotherapy followed by organ preservation in patients with muscle-invasive bladder cancer
    Dracham, Chinna Babu
    Kumar, Narendra
    Kumar, Santosh
    Elangovan, Arun
    Yadav, Budhi Singh
    Mavuduru, Ravimohan S.
    Lal, Anupam
    Gupta, Pramod K.
    Kapoor, Rakesh
    ASIAN JOURNAL OF UROLOGY, 2022, 9 (03) : 318 - 328
  • [47] Phase III prevention trial of Fenretinide in patients with resected non-muscle-invasive bladder cancer
    Sabichi, Anita L.
    Lerner, Seth P.
    Atkinson, E. Neely
    Grossman, H. Barton
    Caraway, Nancy P.
    Dinney, Colin P.
    Penson, David F.
    Matin, Surena
    Kamat, Ashish
    Pisters, Louis L.
    Lin, Daniel W.
    Katz, Ruth L.
    Brenner, Dean E.
    Hemstreet, George P., III
    Wargo, Mary
    Bleyer, Archie
    Sanders, William H.
    Clifford, John L.
    Parnes, Howard L.
    Lippman, Scott M.
    CLINICAL CANCER RESEARCH, 2008, 14 (01) : 224 - 229
  • [48] A phase II study of toripalimab combined with gemcitabine-cisplatin as neoadjuvant therapy for patients with muscle-invasive bladder cancer (MIBC)
    Xu, Abai
    Xu, Peng
    Chen, Chunxiao
    Liu, Zhe
    Jiang, Ning
    Bi, Enguang
    Cao, Manming
    Chen, BinShen
    Liu, Chunxiao
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [49] Study protocol of a phase II clinical trial of oral metformin for the intravesical treatment of non-muscle invasive bladder cancer
    Remco J. Molenaar
    Jons W. van Hattum
    Iris S. Brummelhuis
    Jorg R. Oddens
    C. Dilara Savci-Heijink
    Egbert R. Boevé
    Saskia A. van der Meer
    J. Fred Witjes
    Michael N. Pollak
    Theo M. de Reijke
    Johanna W. Wilmink
    BMC Cancer, 19
  • [50] Study protocol of a phase II clinical trial of oral metformin for the intravesical treatment of non-muscle invasive bladder cancer
    Molenaar, Remco J.
    van Hattum, Jons W.
    Brummelhuis, Iris S.
    Oddens, Jorg R.
    Savci-Heijink, C. Dilara
    Boeve, Egbert R.
    van der Meer, Saskia A.
    Witjes, J. Fred
    Pollak, Michael N.
    de Reijke, Theo M.
    Wilmink, Johanna W.
    BMC CANCER, 2019, 19 (01)
12345